发明名称 |
2,4,6-TRIAMINO-1,3,5-TRIAZINE DERIVATIVE |
摘要 |
<p>This invention relates to an anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient. <??>It was proved that the BEC 1 potassium channel inhibitor has an action to improve learning disorder and is useful as a preventive or therapeutic agent for diseases, preferably dementia, in which the BEC 1 potassium channel is considered to be concerned. <??>Illustratively, it was confirmed by an in vivo test that the BEC 1 potassium channel inhibitor has an action to improve learning disorder. <??>Also, it was found that a compound having 2,4,6-triamino-1,3,5-triazine has a BEC 1 potassium channel inhibitory action.</p> |
申请公布号 |
EP1479397(A1) |
申请公布日期 |
2004.11.24 |
申请号 |
EP20030737464 |
申请日期 |
2003.02.03 |
申请人 |
ASTELLAS PHARMA INC. |
发明人 |
KUBOTA, HIDEKI;SUZUKI, TAKESHI;MIURA, MASANORI;NAKAI, EIICHI;YAHIRO, KIYOSHI;MIYAKE, AKIRA;MOCHIZUKI, SHINOBU;NAKATO, KAZUHIRO |
分类号 |
C07D405/12;A61K31/53;A61P25/28;A61P43/00;C07D251/70;C07D401/12;C07D403/12;C07D409/12;C07D413/12;C07D417/12;C07D453/02;C07D471/04;C07D491/04;(IPC1-7):A61K45/00 |
主分类号 |
C07D405/12 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|